PCSC · Categories · Offerings
PCSC - Public offerings
Perceptive Capital Solutions Corp (PCSC) public offerings - real-time wire coverage filtered to Offerings only.
Recent Offerings for PCSC
- Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders– Extraordinary General Meeting of Perceptive Shareholders Postponed to July 15, 2026NEW YORK, July 9, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (NASDAQ:PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, announced today that the extraordinary general meeting of shareholders of PCSC (the "Extraordinary General Meeting"), originally scheduled for July 9, 2026 at 10:00 a.m. Eastern Time, to approve proposals related to the proposed business combination (the "Business Combination") between PCSC and Freenome Holdings, Inc. ("Freenome"), an early cancer detection company developing blood-based screening tests has been postp
- Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination– Extraordinary General Meeting of Perceptive Shareholders Scheduled for July 9, 2026NEW YORK and BRISBANE, Calif., June 18, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (NASDAQ:PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, and Freenome Holdings, Inc. ("Freenome"), an early cancer detection company developing blood-based screening tests, today announced that the registration statement on Form S-4 (File No. 333-2953772) (as amended, the "Registration Statement"), filed by PCSC and Freenome, relating to the previously announced business combination among PCSC, Freenome and the other parties thereto (the "Business Comb
- Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform– Leading institutional investors commit $240 million through private investment in public equity (PIPE) led by Perceptive Advisors and RA Capital – – Freenome stockholders, PCSC shareholders and PIPE investors will hold shares in the Combined Company that is expected to be listed on Nasdaq under the ticker symbol FRNM – – Business combination is expected to be completed in the first half of 2026 – BRISBANE, Calif. and NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Freenome Holdings, Inc., an early cancer detection company developing blood-based screening tests, and Perceptive Capital Solutions Corp (NASDAQ:PCSC), a special purpose acquisition company (SPAC) sponsored by an affiliate of Perceptive